27/08/2021
EuropaBio comments on the public consultation on blue bioeconomy.
26/07/2021
20/07/2021
03/07/2021
We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
16/06/2021
14/06/2021
07/06/2021
01/06/2021
27/05/2021
2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
25/05/2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
12/05/2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
28/04/2021
EuropaBio is delighted to announce that the Lithuanian Biotechnology Association joins EuropaBio
27/04/2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
25/04/2021
21/04/2021
EuropaBio is delighted to announce that Health and Life Sciences Cluster Bulgaria has joined EuropaBio.